1,755 filings
Page 14 of 88
6-K
6j43z7m s9qomn2t5vsd
11 Sep 17
Teva Names Kåre Schultz as President and Chief Executive Officer
12:00am
S-8
6s7xsq8 h6z11i392d67
7 Sep 17
Registration of securities for employees
12:00am
6-K
o0xvp3y92boor39l
6 Sep 17
Teva To Present New Asthma and COPD Data at the 2017 European Respiratory Society (ERS) International Congress
12:00am
6-K
h06p9haq
5 Sep 17
Teva to Present Fremanezumab Data on Migraine Prevention at the 18thCongress of the International Headache Society
12:00am
SC 13D/A
2iokx7 f210doh
5 Sep 17
Wave Life Sciences Ltd.
12:00am
6-K
3jxbdazg 5w903z4
30 Aug 17
Teva Announces FDA Approval of AUSTEDO® (deutetrabenazine) Tablets for the Treatment of Tardive Dyskinesia in Adults
12:00am
6-K
5cgrpmi6fpah8t 6gfqi
18 Aug 17
Teva Announces Exclusive Launch of Generic Axiron® In the United States
12:00am
UPLOAD
yevjp 3yxv
15 Aug 17
Letter from SEC
12:00am
6-K
mrjuo3n 49
7 Aug 17
Teva Announces FDA Approval of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation Aerosol
12:00am
6-K
nqtygo
3 Aug 17
Current report (foreign)
12:00am
6-K
lcx49oc7vuj7
3 Aug 17
Teva Reports Second Quarter 2017 Financial Results
12:00am
6-K
x4s5ljhr56cj6phyydh
31 Jul 17
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
howx8
28 Jul 17
Teva Announces Launch of Generic Epiduo® In the United States
12:00am
6-K
n5575m5mg07
24 Jul 17
Live Filing
12:00am
6-K
jvxzc12so9fkd9k mb
20 Jul 17
Live Filing
12:00am
CORRESP
59dwuvih
14 Jul 17
Correspondence with SEC
12:00am
6-K
pfvwhj0lr78 1k6nb8y
13 Jul 17
Teva Enhances Board of Directors as All Proposals Approved at Annual General Meeting of Shareholders
12:00am
6-K
7fi8uii x8xg2y
11 Jul 17
Live Filing
12:00am
6-K
g9h 8euar7pwb
11 Jul 17
Data support overnight conversion from tetrabenazine to AUSTEDO™ for the treatment of chorea associated with Huntington disease
12:00am
UPLOAD
tq5 2mmhhxyjbsq4
3 Jul 17
Letter from SEC
12:00am